What You'll Want to Know About Arrowhead Pharmaceuticals' Q3 Update
It's been a fantastic year for Arrowhead Pharmaceuticals (NASDAQ: ARWR) so far in 2019. The stock has more than doubled. The biotech reported good news about its pipeline with its second-quarter results in May.
Despite an overall market sell-off on trade worries to start off this week, investors seemed to be pleased with Arrowhead's third-quarter update announced after the market closed on Monday. The biotech stock rose close to 3.5% in after-hours trading. Here's what you'll want to know about Arrowhead's Q3 update.
Image source: Getty Images.
Quelle Fool.com
